Cargando…

Vitamin D and skeletal health in autoimmune bullous skin diseases: a case control study

BACKGROUND: The presence of hypovitaminosis D in patients with autoimmune bullous skin diseases, such as pemphigus vulgaris (PV) and bullous pemphigoid (BP), is debated. In a previous study we found an increased prevalence of vertebral fractures (VFx) and hypovitaminosis D in PV and BP patients. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Marzano, Angelo Valerio, Trevisan, Valentina, Cairoli, Elisa, Eller-Vainicher, Cristina, Morelli, Valentina, Spada, Anna, Crosti, Carlo, Chiodini, Iacopo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323030/
https://www.ncbi.nlm.nih.gov/pubmed/25644263
http://dx.doi.org/10.1186/s13023-015-0230-0
_version_ 1782356480761004032
author Marzano, Angelo Valerio
Trevisan, Valentina
Cairoli, Elisa
Eller-Vainicher, Cristina
Morelli, Valentina
Spada, Anna
Crosti, Carlo
Chiodini, Iacopo
author_facet Marzano, Angelo Valerio
Trevisan, Valentina
Cairoli, Elisa
Eller-Vainicher, Cristina
Morelli, Valentina
Spada, Anna
Crosti, Carlo
Chiodini, Iacopo
author_sort Marzano, Angelo Valerio
collection PubMed
description BACKGROUND: The presence of hypovitaminosis D in patients with autoimmune bullous skin diseases, such as pemphigus vulgaris (PV) and bullous pemphigoid (BP), is debated. In a previous study we found an increased prevalence of vertebral fractures (VFx) and hypovitaminosis D in PV and BP patients. The present study extends the sample size of the previous one, for investigating the 25-hydroxyvitamin D (25OHVitD) levels in relation with the skeletal health and disease intensity in these patients. METHODS: The previous study was performed in 13 PV and 15 BP patients and 28 controls. Data from 39 additional patients (22 PV and 17 BP) were now added. Eventually, we studied 67 patients (35 PV, 32 BP, 51 females), aged 64.7 ± 16.9 years and 67 age- gender- and body mass index-matched controls. In all subjects, serum 25OHVitD, calcium and alkaline phosphatase (ALP) levels were measured, bone mineral density (BMD) was evaluated by Dual-energy X-ray. Absorptiometry at lumbar spine (LS) and femoral neck (FN) and the presence of VFx were ascertained by visual assessment from spinal radiographs. In patients, the disease intensity was evaluated by the autoimmune bullous skin disorder intensity score (ABSIS). RESULTS: As compared with controls, both PV and BP patients showed lower 25OHVitD (22.2 ± 11.1 vs 13.9 ± 8.3 ng/mL, p < 0.001 and 22.4 ± 14.9 vs 9.5 ± 7.7 ng/mL, p < 0.0001, respectively) and higher prevalence of severe hypovitaminosis D (22.9 vs 48.6%, p < 0.02 and 31.1 vs 75.0%, p < 0.0001, respectively) and VFx (28.6 vs 57.1%, p = 0.03 and 34.4 vs 62.5%, P = 0.02, respectively). In both PV and BP patients, LS and FN BMD did not differ from controls. In the whole patients’ group, ABSIS score was inversely associated with 25OHVitD levels (R = −0.36, p < 0.005), regardless of age (β = −3.2, P = 0.009). CONCLUSIONS: PV and BP patients have an increased prevalence of hypovitaminosis D and VFx. The extended study shows, for the first time, that the 25OHVitD levels are inversely associated with disease intensity and that VFx occur in spite of a not reduced BMD. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13023-015-0230-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4323030
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43230302015-02-11 Vitamin D and skeletal health in autoimmune bullous skin diseases: a case control study Marzano, Angelo Valerio Trevisan, Valentina Cairoli, Elisa Eller-Vainicher, Cristina Morelli, Valentina Spada, Anna Crosti, Carlo Chiodini, Iacopo Orphanet J Rare Dis Research BACKGROUND: The presence of hypovitaminosis D in patients with autoimmune bullous skin diseases, such as pemphigus vulgaris (PV) and bullous pemphigoid (BP), is debated. In a previous study we found an increased prevalence of vertebral fractures (VFx) and hypovitaminosis D in PV and BP patients. The present study extends the sample size of the previous one, for investigating the 25-hydroxyvitamin D (25OHVitD) levels in relation with the skeletal health and disease intensity in these patients. METHODS: The previous study was performed in 13 PV and 15 BP patients and 28 controls. Data from 39 additional patients (22 PV and 17 BP) were now added. Eventually, we studied 67 patients (35 PV, 32 BP, 51 females), aged 64.7 ± 16.9 years and 67 age- gender- and body mass index-matched controls. In all subjects, serum 25OHVitD, calcium and alkaline phosphatase (ALP) levels were measured, bone mineral density (BMD) was evaluated by Dual-energy X-ray. Absorptiometry at lumbar spine (LS) and femoral neck (FN) and the presence of VFx were ascertained by visual assessment from spinal radiographs. In patients, the disease intensity was evaluated by the autoimmune bullous skin disorder intensity score (ABSIS). RESULTS: As compared with controls, both PV and BP patients showed lower 25OHVitD (22.2 ± 11.1 vs 13.9 ± 8.3 ng/mL, p < 0.001 and 22.4 ± 14.9 vs 9.5 ± 7.7 ng/mL, p < 0.0001, respectively) and higher prevalence of severe hypovitaminosis D (22.9 vs 48.6%, p < 0.02 and 31.1 vs 75.0%, p < 0.0001, respectively) and VFx (28.6 vs 57.1%, p = 0.03 and 34.4 vs 62.5%, P = 0.02, respectively). In both PV and BP patients, LS and FN BMD did not differ from controls. In the whole patients’ group, ABSIS score was inversely associated with 25OHVitD levels (R = −0.36, p < 0.005), regardless of age (β = −3.2, P = 0.009). CONCLUSIONS: PV and BP patients have an increased prevalence of hypovitaminosis D and VFx. The extended study shows, for the first time, that the 25OHVitD levels are inversely associated with disease intensity and that VFx occur in spite of a not reduced BMD. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13023-015-0230-0) contains supplementary material, which is available to authorized users. BioMed Central 2015-02-03 /pmc/articles/PMC4323030/ /pubmed/25644263 http://dx.doi.org/10.1186/s13023-015-0230-0 Text en © Marzano et al.; licensee Biomed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Marzano, Angelo Valerio
Trevisan, Valentina
Cairoli, Elisa
Eller-Vainicher, Cristina
Morelli, Valentina
Spada, Anna
Crosti, Carlo
Chiodini, Iacopo
Vitamin D and skeletal health in autoimmune bullous skin diseases: a case control study
title Vitamin D and skeletal health in autoimmune bullous skin diseases: a case control study
title_full Vitamin D and skeletal health in autoimmune bullous skin diseases: a case control study
title_fullStr Vitamin D and skeletal health in autoimmune bullous skin diseases: a case control study
title_full_unstemmed Vitamin D and skeletal health in autoimmune bullous skin diseases: a case control study
title_short Vitamin D and skeletal health in autoimmune bullous skin diseases: a case control study
title_sort vitamin d and skeletal health in autoimmune bullous skin diseases: a case control study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323030/
https://www.ncbi.nlm.nih.gov/pubmed/25644263
http://dx.doi.org/10.1186/s13023-015-0230-0
work_keys_str_mv AT marzanoangelovalerio vitamindandskeletalhealthinautoimmunebullousskindiseasesacasecontrolstudy
AT trevisanvalentina vitamindandskeletalhealthinautoimmunebullousskindiseasesacasecontrolstudy
AT cairolielisa vitamindandskeletalhealthinautoimmunebullousskindiseasesacasecontrolstudy
AT ellervainichercristina vitamindandskeletalhealthinautoimmunebullousskindiseasesacasecontrolstudy
AT morellivalentina vitamindandskeletalhealthinautoimmunebullousskindiseasesacasecontrolstudy
AT spadaanna vitamindandskeletalhealthinautoimmunebullousskindiseasesacasecontrolstudy
AT crosticarlo vitamindandskeletalhealthinautoimmunebullousskindiseasesacasecontrolstudy
AT chiodiniiacopo vitamindandskeletalhealthinautoimmunebullousskindiseasesacasecontrolstudy